-
The clinical utility of genomics in childhood cancer extends beyond targetable mutations
Study
EGAS00001006034
-
Loss of Epigenetic Barrier is Required for Enhancer Hijacking-Mediated Oncogenic Transcription
Study
EGAS00001006140
-
The clinical utility of genomics in childhood cancer extends beyond targetable mutations - WGS data
Study
EGAS00001006610
-
Palbociclib resistance analyses on breast cancer bone metastasis PDX
Study
EGAS00001006428
-
Analyses of IACS-010759 treatment resistance on breast cancer bone metastases
Study
EGAS00001006429
-
Treatment-mediated selection of lethal prostate cancer clones defined by copy number architectures
Study
EGAS00001006598
-
The clinical utility of genomics in childhood cancer extends beyond targetable mutations - Cancer Panel data
Study
EGAS00001006642
-
Diet driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome
Study
EGAS00001006982
-
Molecular features of adenomas predicting metachronous colorectal cancer: a nested-case control study
Study
EGAS00001007039
-
Submission 10 - study_title 2
Study
EGAS50000000073
-
Immune trajectory of response and adverse effect in immunotherapy-treated hepatocellular carcinoma
Study
EGAS00001004843
-
Genomic analysis of patient-derived xenograft models reveals intratumor-heterogeneity in endometrial cancer and can predict tumor growth inhibition with talazoparib
Study
EGAS00001004666
-
Early ctDNA molecular response captures therapeutic response in the first stage of CCTG BR.36 ctDNA-directed, multi-center phase II study of molecular response adaptive immunotherapy in non-small cell lung cancer
Study
EGAS00001007298
-
Pre-neoplastic liver colonization by 11p15.5 altered mosaic cells in young children with hepatoblastoma
Study
EGAS00001006692
-
Oesophageal_Adenocarcinoma_Organoid_ATAC
Study
EGAS00001003890
-
RNA sequencing and Illumina 2.5M SNP array data collected from 675 commonly used human cancer cell lines.
Study
EGAS00001000610
-
SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors
Study
EGAS00001007590
-
Genetic Landscape of Esophageal Squamous Cell Carcinoma Defined by Exome Sequencing on Chinese Patient Cohort and Cell Lines
Study
EGAS00001000932
-
Multimodal Epigenetic Sequencing Analysis (MESA) of Cell-free DNA for Non-invasive Cancer Detection
Study
EGAS00001006462
-
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification (H021)
Study
EGAS00001006706
-
Pediatric Patient-Derived-Xenograft development in MAPPYACTS – international pediatric cancer precision medicine trial in relapsed and refractory tumors
Study
EGAS00001007327
-
Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer
Study
EGAS00001007430
-
Single cell RNA sequencing of normal endometrial derived organoids uncovers novel cell type markers for prognostication
Study
EGAS00001004466
-
Kidney_tumour_RNA
Study
EGAS00001002487
-
Orphan_Tumour_Study___RNAseq
Study
EGAS00001002534
-
RNA-seq of Liver Cancer
Study
EGAS00001002879
-
Oncogenic Ectodomain deletion of FGFR1 caused by Breakage-Fusion-Bridges in Squamous Cell lung Cancer
Study
EGAS00001005059
-
Oesophageal_Adenocarcinoma_Organoid_10x
Study
EGAS00001003191
-
One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids
Study
EGAS00001006886
-
The genomic imprint of cancer therapies helps timing the formation of metastases
Study
EGAS00001003416
-
RNAseq
Study
EGAS00001007212
-
TNBC ctDNA Targeted Panel
Study
EGAS00001006937
-
Colon adenomas and adenocarcinomas and matched mucosae
Study
EGAS00001007255
-
Oesophageal_Adenocarcinoma_Organoid_Hi_C
Study
EGAS00001003122
-
X10_sequencing_of_Oesophageal_Adenocarcinoma_Organoids
Study
EGAS00001003264
-
Oesophageal_Adenocarcinoma_Organoids_Iso_Seq
Study
EGAS00001004051
-
Oesophageal_Adenocarcinoma_Organoid_PacBio
Study
EGAS00001007163
-
Chip_seq_oesophageal_adenocarcinoma_
Study
EGAS00001007180
-
Adult granulosa cell tumor WGS data cohort with corresponding reference germline WGS data
Study
EGAS00001004249
-
Ultra-deep targeted sequencing for studying the accumulation of somatic mutations in cancer-free human skin
Study
EGAS00001004279
-
PFA ependymoma cancer study
Study
EGAS00001004312
-
Elucidating the heterogeneity of immunotherapy response and immune-related toxicities by longitudinal ctDNA and immune cell compartment tracking in lung cancer
Study
EGAS00001007291
-
RNAseq of Colorectal cancer organoid-stroma biobank cohort
Study
EGAS00001007300
-
Clonal_selection_after_gene_therapy_in_SCD___Duplex_sequencing
Study
EGAS00001007253
-
Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I Trial
Study
EGAS00001007210
-
Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions(H021/INF)
Study
EGAS00001006939
-
Radiotherapy_induced_sarcoma
Study
EGAS00001000138
-
INSPIRE multi-timepoint cfMeDIP dataset
Dataset
EGAD00001011312
-
Idiosyncratic and generic single nuclei and spatial transcriptional patterns in papillary and anaplastic thyroid cancers
Study
EGAS00001007574
-
Genome and transcriptome sequence data from a metastatic pancreatic neuroendocrine patient
Dataset
EGAD00001005763
-
IMPRESS: Improved Methylation Profiling using Restriction Enzymes and smMIP Sequencing, Combined with New Biomarker Panel, Creating Multi-Cancer Detection Assay
Study
EGAS00001007559
-
Oesophageal adenocarcinoma whole exome and RNA-seq raw sequencing data
Study
EGAS00001005957
-
Tumour evolvability metrics predict recurrence in advanced localised prostate cancer (tumour data)
Study
EGAS00001006096
-
Benchmarking for alignment and variant calling
Study
EGAS00001007819
-
PD-L1 blockade immunotherapy rewires cancer-induced emergency myelopoiesis
Study
EGAS00001007873
-
Early evolutionary branching across spatial domains predisposes to clonal replacement under chemotherapy in neuroblastoma
Study
EGAS00001007650
-
Whole Genome Sequence and RNASeq Samples for Lung Cancer
Study
EGAS00001007832
-
Subclonal evolution of four ER+ breast cancers determined by WGS and scRNA-Seq
Study
EGAS00001002436
-
Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancer
Study
EGAS00001003388
-
TRACERx 100: RNAseq data from the first 100 TRACERx tumours
Study
EGAS00001003458
-
Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer
Study
EGAS00001004030
-
Clonal fitness inferred from timeseries modeling of single cell cancer genomes
Study
EGAS00001004448
-
BMP4 and temozolomide synergize in the majority of patient derived glioblastoma cultures
Study
EGAS00001007095
-
Single-cell RNA-seq data from metastatic ovarian cancer for quality control study
Study
EGAS00001005066
-
Interactions between the tumor and the systemic response of breast cancer patients
Study
EGAS00001001804
-
RNA-sequencing data from 195 B-cell precursor acute lymphoblastic leukemias and mate pair whole genome sequencing data from 15 B-cell precursor acute lymphoblastic leukemias
Study
EGAS00001001795
-
Single Cell Dissection of the Tumour Microenvironment Reveals Dynamic Interplay Shaping the Tumour Immunity Continuum in Ovarian Cancer
Study
EGAS00001004935
-
Longitudinal Single-Cell Profiling Reveals Molecular Heterogeneity and Tumor-Immune Evolution in Refractory Mantle Cell Lymphoma
Study
EGAS00001005019
-
Spatial Transcriptomics on prostate cancer heterogeneity
Study
EGAS00001003001
-
Pseudotime_ordering_of_cell_cycle_state
Study
EGAS00001003293
-
Multiregion Whole Exome and Smart-Seq3 single cell RNA sequencing of Breast Tumors
Study
EGAS00001006851
-
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Study
EGAS00001000226